Ritonavir and disulfiram have potential to inhibit caspase-1 mediated inflammation and reduce neurological sequelae after minor blast exposure

Medical Hypotheses

Volumn 72, Issue 2, 2009, Pages 150-152

  Foley, Kevin ^a   Kast, Richard E ^b   Altschuler, Eric L ^c  

^a NORTHERN MICHIGAN UNIVERSITY   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c University of Medicine and Dentistry of New Jersey   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; AMPRENAVIR PHOSPHATE; ATAZANAVIR; DARUNAVIR; DISULFIRAM; INDINAVIR; INTERLEUKIN 1BETA CONVERTING ENZYME; NELFINAVIR; RITONAVIR; SAQUINAVIR; TIPRANAVIR;

ADVERSE OUTCOME; ALCOHOLISM; ARTICLE; BLAST INJURY; BRAIN CONCUSSION; BRAIN CONTUSION; DRUG INHIBITION; ENZYME ACTIVATION; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; NEUROPSYCHIATRY; NONHUMAN; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT; UPREGULATION;

CASPASE 1; CRANIOCEREBRAL TRAUMA; DISULFIRAM; HUMANS; INFLAMMATION; RITONAVIR;

ANIMALIA;

EID: 57749200154     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.08.024     Document Type: Article

References (32)

1. Jones E., Fear N.T., and Wessely S. Shell shock and mild traumatic brain injury: a historical review. Am J Psychiat 164 (2007) 1641-1645
2. Warden D. Military TBI during the Iraq and Afghanistan wars. J Head Trauma Rehabil 21 (2006) 398
3. Trudeau D.L., Anderson J., Hansen L.M., Shagalov D.N., Schmoller J., Nugent S., et al. Findings of mild traumatic brain injury in combat veterans with PTSD and a history of blast concussion. J Neuropsy Clin Neurosci 10 (1998) 308
4. Taber K.H., Warden D.L., and Hurley R.A. Blast-related traumatic brain injury: what is known?. J Neuropsy Clin Neurosci 18 (2006) 141-145
5. Bhattacharjee Y. Neuroscience shell shock revisited: solving the puzzle of blast trauma. Science 319 5862 (2008) 406-408
6. Heitger M.H., Jones R.D., Dalrymple-Alford J.C., Frampton C.M., Ardagh M.W., and Anderson T.J. Mild head injury, a close relationship between motor function at 1 week post-injury and overall recovery at 3 and 6 months. J Neurol Sci 253 (2007) 34
7. Ropper A.H., and Gorson K.C. Clinical practice. Concussion. N Engl J Med 356 (2007) 166
8. DePalma R.G., Burris D.G., Champion H.R., and Hodgson M.J. Blast injuries. N Engl J Med 352 (2005) 1335
9. Garth R.J. Blast injury of the ear: an overview and guide to management. Injury 26 (1995) 363
10. Felderhoff-Mueser U., Schmidt O.I., Oberholzer A., Buhrer C., and Stahel P.F. IL-18: a key player in neuroinflammation and neurodegeneration?. Trends Neurosci 28 (2005) 487
11. Felderhoff-Mueser U., Sifringer M., Polley O., Dzietko M., Leineweber B., Mahler L., et al. Caspase-1-processed interleukins in hyperoxia-induced cell death in the developing brain. Ann Neurol 57 (2005) 50
12. Morita-Fujimura Y., Fujimura M., Kawase M., Murakami K., Kim G.W., and Chan P.H. Inhibition of interleukin-1beta converting enzyme family proteases (caspases) reduces cold injury-induced brain trauma and DNA fragmentation in mice. J Cereb Blood Flow Metab 19 6 (1999) 634-642
13. Hara H., Friedlander R.M., Gagliardini V., Ayata C., Fink K., Huang Z., et al. Inhibition of interleukin-1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 94 (1997) 2007
14. Kim N.G., Lee H., Son E., Kwon O.Y., Park J.Y., Park J.H., et al. Hypoxic induction of caspase-11/caspase-1/interleukin-1beta in brain microglia. Brain Res Mol Brain Res 114 (2003) 107
15. Faubel S., and Edelstein C.L. Caspases as drug targets in ischemic organ injury. Curr Drug Targets Immune Endocr Metabol Disord 5 (2005) 269
16. Ross J., Brough D., Gibson R.M., Loddick S.A., and Rothwell N.J. A selective, non-peptide caspase-1 inhibitor, VRT-018858, markedly reduces brain damage induced by transient ischemia in the rat. Neuropharmacology 53 5 (2007) 638-642
17. Clark R.S., Kochanek P.M., Chen M., Watkins S.C., Marion D.W., Chen J., et al. Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury. FASEB J 13 (1999) 813
18. Masliah E., Mallory M., Alford M., Tanaka S., and Hansen L.A. Caspase dependent DNA fragmentation might be associated with excitotoxicity in Alzheimer disease. J Neuropathol Exp Neurol 57 11 (1998) 1041-1052
19. Fink K.B., Andrews L.J., Butler W.E., Ona V.O., Li M., Bogdanov M., et al. Reduction of post-traumatic brain injury and free radical production by inhibition of the caspase-1 cascade. Neuroscience 94 (1999) 1213-1218
20. Brough D., and Rothwell N.J. Caspase-1-dependent processing of pro-interleukin-1beta is cytosolic and precedes cell death. J Cell Sci 120 (2007) 772-781
21. O'Shea E., Sanchez V., Orio L., Escobedo I., Green A.R., and Colado M.I. 3,4-Methylenedioxymethamphetamine increases pro-interleukin-1beta production and caspase-1 protease activity in frontal cortex, but not in hypothalamus, of dark agouti rats: role of interleukin-1beta in neurotoxicity. Neuroscience 135 (2005) 1095-1105
22. Mariathasan S., and Monack D.M. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 7 (2007) 31
23. Sifringer M., Stefovska V., Endesfelder S., Stahel P.F., Genz K., Dzietko M., et al. Activation of caspase-1 dependent interleukins in developmental brain trauma. Neurobiol Dis 25 (2007) 614-622
24. Yakovlev A.G., Knoblach S.M., Fan L., Fox G.B., Goodnight R., and Faden A.I. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J Neurosci 17 (1997) 7415-7424
25. Tweedie D., Milman A., Holloway H.W., Li Y., Harvey B.K., Shen H., et al. Apoptotic and behavioral sequelae of mild brain trauma in mice. J Neurosci Res 85 (2007) 805-815
26. Harada J., and Sugimoto M. Inhibitors of interleukin-1beta converting enzyme family proteases (caspases) prevent apoptosis without affecting decreased cellular ability to reduce 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide in cerebellar granule neurons. Brain Res 793 (1998) 231
27. Marchionini D.M., Collier T.J., Pitzer M.R., and Sortwell C.E. Reassessment of caspase inhibition to augment grafted dopamine neuron survival. Cell Transplant 13 (2004) 273-282
28. Sloand E.M., Kumar P.N., Kim S., Chaudhuri A., Weichold F.F., and Young N.S. Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo. Blood 94 (1999) 1021-1027
29. Sloand E.M., Maciejewski J., Kumar P., Kim S., Chaudhuri A., and Young N. Protease inhibitors stimulate hematopoiesis and decrease apoptosis and ICE expression in CD34(+) cells. Blood 96 (2000) 2735-2739
30. Vlahakis S.R., Bennett S.A., Whitehead S.N., and Badley A.D. HIV protease inhibitors modulate apoptosis signaling in vitro and in vivo. Apoptosis 12 (2007) 969-977
31. Weichold F.F., Bryant J.L., Pati S., Barabitskaya O., Gallo R.C., and Reitz Jr. M.S. HIV-1 protease inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cells. J Hum Virol 2 (1999) 261-269
32. Nobel C.S., Kimland M., Nicholson D.W., Orrenius S., and Slater A.F. Disulfiram is a potent inhibitor of proteases of the caspase family. Chem Res Toxicol 10 12 (1997) 1319-1324